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Background: Previous study showed that the aqueous extract of the stem bark of Cinnamomum zeylanicum
possesses antihypertensive and vasodilatory properties. The present work investigates the acute and chronic
antihypertensive effects of the methanol extract of Cinnamomum zeylanicum stem bark (MECZ) in L-NAME-induced
hypertensive rats.
Methods: The acute antihypertensive effects of MECZ (5, 10 and 20 mg/kg) administered intravenously were
evaluated in rats in which acute arterial hypertension has been induced by intravenous administration of L-NAME
(20 mg/kg). For chronic antihypertensive effects, animals were treated with L-NAME (40 mg/kg/day) plus the vehicle
or L-NAME (40 mg/kg/day) in combination with captopril (20 mg/kg/day) or MECZ (300 mg/kg/day) and compared
with control group receiving only distilled water. All drugs were administered per os and at the end of the
experiment that lasted for four consecutive weeks, blood pressure was measured by invasive method and blood
samples were collected for the determination of the lipid profile. The heart and aorta were collected, weighed and
used for both histological analysis and determination of NO tissue content.
Results: Acute intravenous administration of C. zeylanicum extract (5, 10 and 20 mg/kg) to L-NAME-induced
hypertensive rats provoked a long-lasting decrease in blood pressure. Mean arterial blood pressure decreased by
12.5%, 26.6% and 30.6% at the doses of 5, 10 and 20 mg/kg, respectively. In chronic administration, MECZ and
captopril significantly prevented the increase in blood pressure and organs’ weights, as well as tissue histological
damages and were able to reverse the depletion in NO tissue’s concentration. The MECZ also significantly lower the
plasma level of triglycerides (38.1%), total cholesterol (32.1%) and LDL-cholesterol (75.3%) while increasing that of
HDL-cholesterol (58.4%) with a significant low atherogenic index (1.4 versus 5.3 for L-NAME group).
Conclusion: MECZ possesses antihypertensive and organ protective effects that may result from its ability to
increase the production of the endogenous NO and/or to regulate dyslipidemia.
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Essential (or primary) hypertension accounts for approxi-
mately 90% to 95% of patients diagnosed with hypertension
[1] and it is mainly caused by endothelial dysfunction which
results from NO deficiency. In fact, it has been found that
vascular endothelium of hypertensive patients produces less
nitric oxide, a key regulator of cardiovascular system and
metabolic homeostasis [2]. It acts as an antiatherogenic
agent by inhibiting LDL oxidation, platelets aggregation,
vascular smooth muscle proliferation, adhesion molecules
expression and adhesion of monocytes to the endothelium
[3,4]. Moreover, NO is known to be an anti-hypertrophic
agent [5]. The inhibition of NO production by L-arginine
analogue like Nω Nitro-L- arginine methyl-ester (L-NAME)
therefore results in arterial hypertension, dyslipidemia and
histological damages. L-NAME-induced hypertension is
thus a suitable model to study the cardiovascular effects of
new active substances.
Despite the large number of antihypertensive drugs
and the progresses made in the efficacy and tolerability
of these agents, it is acknowledged that less than 25% of
treated individuals achieve target blood pressure (BP)
(i.e. <140/90 mmHg) [6]. Trial outcomes have shown
that each agent is associated with relative benefits and
drawbacks, often within the context of various patient
characteristics such as age, co-morbidities and risk
status [7]. The current trend towards lower BP goals
suggests that more effective and better tolerated antihy-
pertensive therapies will be needed, of which natural
products can be considered as one of the potential
sources. Indeed, various plant preparations have been
used and claimed to have antihypertensive effects. The
antihypertensive effects of some of these plants have
been validated and others disproved. One of the plants
used for the treatment of hypertension is Cinnamomum
zeylanicum (Lauraceae). It is a native of Sri Lanka and
south India [8]. Moderately sized tree, up to 2-16 m tall
and 60 cm in diameter at breast height, Cinnamomum
zeylanicum is covered with a thick, scabrous bark. The
leaves are petiolate, opposite for the most part, cori-
aceous, obtusely pointed with three nerves; the lateral
nerves vanishing as they approach the apex. When
mature, the leaves are of a shiny green colour on their
upper surface, and lighter colour beneath. The flowers
are small, white, and arranged in axillaries and terminal
panicles. The fruit is an oval berry, which adheres like
the acorn to the receptacle, it’s larger than the black
currant and when ripe has a bluish-brown surface,
diversified with numerous white spots [9]. Traditionally,
the stem bark of this plant is utilized in the management
of various ailments in many Cameroonian communities.
For example, it is used for the treatment of gastrointes-
tinal disorders, typhoid fever, rheumatism and muscular
pain. It is also used as an aphrodisiac and in cases ofcardiovascular disorders including high blood pressure.
Many pharmacological investigations carried out on C.
zeylanicum demonstrated a number of useful effects in-
cluding anti-nociceptive and anti-inflammatory [10],
antidiabetic [11]. Phytochemical studies of C. zeylanicum
revealed the presence of phenolic constituents in the fruits
[12]. The analyses of the stem bark revealed the presence
of tannin, mucilage, coumarine and essential oil. Cinna-
maldehyde and camphor are major compounds present in
stem-bark oil of this plant [13]. We previously showed
that the aqueous extract of this plant possesses acute anti-
hypertensive and vasorelaxant effects [14].
The present study attempted to evaluate the acute and
chronic antihypertensive effects of the methanol extract
of the stem bark of C. zeylanicum in L-NAME-induced
hypertensive rats.
Methods
Plant collection and extraction
Fresh barks of C. zeylanicum were harvested in Njombe,
Moungo Division in the Littoral Region of Cameroon in
January 2007. The plant material was identified at the
National Herbarium in Yaounde, in comparison to the
voucher specimen number SRFC/22309. The barks were
air-dried and ground to a fine powder. 800 g of the
powder obtained were soaked at room temperature in 3
l of methanol for 48 h, with occasional shaking. After
filtration, the filtrate was concentrated by evaporation at
70°C under reduced pressure on a rotary evaporator to
afford 45 g of the methanol extract, corresponding to an
extraction yield of 5.6%. This extract was dissolved in
DMSO (4%) for daily used.
The major phytochemical groups were determined
using the Lieberman Buchard, ferric chloride, copo of
magnesium and Vanillin-sulphuric acid tests. Sterols,
polyphenolic compounds, flavonoids, alkaloids and sapo-
nins were identified in the extract.
Animals and experimental design
Male Wistar rats, aged 12–16 weeks and weighing 150
to 250 g were randomly selected from our colony. They
were raised in the animal house of the Faculty of
Sciences, University of Dschang, Cameroon. Animals
were exposed to daily 12 h light–dark cycle with free
access to a standard animal diet and tap water. The
effects of Cinnamomum zeylanicum methanol extract
(MECZ) were examined acutely and chronically in vivo
on mean arterial blood pressure (MABP) of rats previously
treated with L-NAME.
Ethical consideration
Experimental protocols used in this study were approved
by the Laboratory committee (Laboratory of Animal
Physiology and Phytopharmacology, Department of Animal
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the standard ethical guidelines for laboratory animal use
and care as described in the European Community guide-
lines; EEC Directive 86/609/EEC, of the 24th November
1986 [15].
Blood pressure and heart rate measurement
Blood pressure and cardiac frequency were determined
by the invasive method. Brietly, Animals were anaes-
thetized by intraperitoneal administration of sodium
thiopental at the dose of 50 mg/kg and a catheter was
implanted in the femoral vein for drug administration.
Another catheter was inserted in the left carotid artery
for direct blood pressure measurement. Both catheters
were filled with glucose-saline heparinized solution.
The catheter inserted in the carotid artery was con-
nected to a blood pressure transducer model Ugo
Basile PRC 21k-10 coupled to an Ugo Basile Unirecord
model 7050 for blood pressure recording. A stabilisa-
tion period of 30 minutes was observed before any
recording. Heart frequency was determined by the use
of pulse intervals.
Experimental procedure
For acute antihypertensive study, a solution of L-NAME,
an inhibitor of nitric oxide synthase was intravenously
injection to normotensive Wistar rats (20 mg/kg) after the
stabilization period at corresponding volume of 100 μl/
100 g bw. MECZ was administered intravenously at the
doses of 5, 10 or 20 mg/kg, twenty minutes after L-NAME
administration, when the rise in blood pressure induced
by L-NAME had reached the maximum [16].
In the chronic study, male Wistar rats were randomly
divided into four groups of eight rats each. The first
group (control) received a solution of DMSO 4% daily,
while the second one (L-NAME group) received
L-NAME (40 mg/kg/day) plus the vehicle. The third
group was treated every day with a combined solution
of L-NAME (40 mg/kg/day) and captopril (LN-Capto;
20 mg/kg/day) while the forth group, received a combin-
ation of L-NAME (40mg/kg/day) and MECZ (LN-MECZ;
300 mg/kg/day). All the treatments were administered
daily by gastric intubation on non-anesthetized animals
for 4 weeks at the corresponding volume of 1 ml/100 g
bw. The intubation was done daily, on non-anesthetized
animals. The dose of the extract was determined based
on previous results. At the end of the treatment, animals
were anaesthetized by intraperitoneal administration of
sodium thiopental (50 mg/kg) for blood pressure meas-
urement. Immediately after blood pressure measure-
ment, blood samples were collected from the abdominal
artery, and centrifuged at 3000 rpm for 15 minutes. The
plasma obtained was kept at −20°C for lipid assay.
Thereafter, the heart and the thoracic aorta werecollected, washed in saline and weighed. The heart was
dissected out for the evaluation of the left ventricular
mass. Three organs’ samples were fixed with 10% forma-
lin in saline while the five others were used for NO
evaluation.Biochemical analysis
The concentrations of total cholesterol (TC), high
density lipoprotein (HDL) and triglycerides (TG) in
plasma were determined spectrophotometrically using
a commercially available kit Dialab and Helios Epsilon
spectrophotometer. Low density lipoprotein (LDL)
content was calculated from the other lipid parameters
according to the [17] equation: LDL = TC–(TG/5)–
HDL. The atherogenic index was calculated using the
formula [18]: Atherogenic Index.
The left ventricle and aorta were homogenized in a
carbonate buffer solution, and centrifuged at 4000 rpm
for 15 minutes. The supernatant obtained was used
to measure spectrophotometrically tissue concentra-
tion of nitric oxide (NO) as previously described by
[19]. Briefly, 300 μl of sample were allowed to react
with Griess reagent (1% sulfanilamide, 0.1% N-1-
naphthylethylenediamine dihydrochloride and 2.5%
phosphoric acid) at room temperature for 10 min, and
then the absorbance was read at 530 nm. The NO con-
centration was determined by using NaNO2 standard
curve.Aortic and left ventricular histological analysis
Fixed left ventricle and aorta were dehydrated and em-
bedded in paraffin. 5 μm thick sections were mounted
on glass slides. After deparaffinization and rehydration,
they were stained with either Hematoxylin-Eosin or
Van Gieson trichrome solutions in order to assess
histological injuries and collagen accumulation in
tissues. Histological analysis was performed with light
microscope. The media thickness of aorta defined as
the distance between the internal and external elastic
lamina was determined using the following argument.
Each photo have a bar corresponding to a given
distance (aμm). Knowing that the magnification used
was 400, the length (L) of each bar was then calculated
using the formula: L = aμm/400.Drugs used
L-NAME was obtained from Fluka (Germany), sodium
thiopental from Rotex Media (Germany), Heparin from
Sanofi (France) and captopril was obtained from the
Sahib Singh Agencies (India). All test solutions, includ-
ing Krebs’ solution were freshly prepared in distilled
water.
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Statistical analysis was performed using GraphPad Prism
version 5.0. All results are expressed as means ± standard
error of the mean. Data were analysed using one-way
analysis of variance (ANOVA) followed by Tukeys’post
test. Differences between means were considered to be
significant when p < 0.05.
Results
Acute antihypertensive effects of the methanol extract of
Cinnamomum zeylanicum
Figure 1 shows the acute effects of MECZ on mean
arterial blood pressure (MABP) examined in vivo in
L-NAME induced hypertensive rats. L-NAME injected
intravenously at the dose of 20 mg/kg in normotensive
Wistar rats induced a sustained arterial hypertension
which persisted for more than one hour and half with a
MABP of 160.33 ± 3.82 mm Hg. Immediately following
intravenous administration, MECZ induced a significant
(p < 0.001) decrease in MABP. The lowest dose (5 mg/kg)
reduced the elevated blood pressure by 46.4 ± 10.6%.
The MABP dropped from 160 ± 4.02 mm Hg to 62.13 ±
11.28 mm Hg. In animals receiving the doses of 10 and
20 mg/kg, the MABP dropped suddenly after plant
administration from 159.46 ± 5.77 mm Hg to 55.46 ±
7.31 mm Hg and from 176.66 ± 6.86 mm Hg to 83.46 ±
16.03 mm Hg; corresponding to an immediate reduction
in MABP of 68.9 ± 4.8% and 50.7 ±9.5% respectively.
The immediate fall in blood pressure induced by pre-
vious doses (5, 10 and 20 mg/kg) of the extract was
followed by a long-lasting and dose-related antihyper-
tensive effects that lasted for more than one hour with a
corresponding decreases of 12.51 ± 1.7%, 27.23 ± 3.1%
and 30.9 ± 3.1%, respectively.Figure 1 Effect of the methanol extract from Cinnamomum. zeylanicu
induced hypertensive rats. Each point represents the mean±SEM (n=5); α
initial value (0 minute). **p<0.01 and ***p<0.001 significantly different com
L-NAME administration.Chronic antihypertensive effects of the methanol extract
of Cinnamomum zeylanicum
Animals that received only L-NAME (40 mg/kg/day)
were hypertensive after four weeks of treatment. Con-
comitant administration of L-NAME with captopril (LN-
Capto; 20 mg/kg/day) or MECZ (LN-MECZ; 300 mg/
kg/day) prevented the installation of hypertension as
depicted in Figure 2. MABP value was 135.6 mm Hg in
L-NAME treated rats versus 104 ± 6.83 mm Hg and
108.26 ± 3.1 mm Hg in the LN-Capto and LN-MECZ
groups respectively. However, no significant change in
heart rate was observed between experimental groups
(Figure 2).
Long-term effects of the methanol extract of
Cinnamomum zeylanicum on the final body weight and
some organs weight
In the control group, the relative body weight
increased by 122.5 ± 2.5% compared to initial value.
This parameter was significantly low (p < 0.01) in L-
NAME treated rats where the body weight increased
only by 107.9 ± 4.3%. Contrary to captopril (112 ±
3.1%) slightly prevented the body weight loss induced
by L-NAME as compared to the control group while
the MECZ did not prevent body weight loss, with the
relative body weight (102.1 ± 4.5%) significantly low
(p < 0.01) compared to that of the control group
(Figure 3).
In contrast to the effects observed on the body weight,
long-term administration of L-NAME significantly
(p < 0.001) increased both aorta (160.2 ± 15.3 mg/
100 g bw versus 58 ± 4 mg/100g bw in the control
group) and left ventricle (1.14 ± 0.11 g/100 g bw versus
0.68 ± 0.04 g/100 g bw in the control group) weights.m stem bark on the mean arterial blood pressure in L-NAME-
p<0.05, βp<0.01 and γp<0.001 significantly different compared to the
pared to the value 20 minutes after


















































Figure 2 Effects of the methanol extract of Cinnamomum
zeylanicum on MABP and heart rate (B). Values are Mean±SEM
(n=5); βp<0.01 compared to the control group; **p<0.01 and
***p<0.01 compared to the L-NAME group.
























Figure 3 Effects of chronic treatment on the rat relative body
weight. n=5; **p<0.01 significantly different compared to the
control.
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NAME administration was significantly (p < 0.01)
prevented by captopril and MECZ (Figure 4).
Aortic and left ventricle histomorphologies
Hematoxylin & Eosin staining revealed in L-NAME
treated rat, an aortic media hypertrophy, characterized
by an increase in the vessel section area (58 ± 0.11 μm
versus 43 ± 0.03 μm in the control group). Moreover,
cell accumulation on the endothelial wall was also
noticed; which could lead to endothelial impairment.These vascular morphological damages were almost
completely prevented by captopril (45 ± 0.21 μm versus
58 ± 0.11 μm in the L-NAME group) as well as the plant
extract (45 ± 0.4 μm versus 58 ± 0.11 μm in the L-NAME
group) (Figure 5A). Van Gieson trichrome revealed left
ventricular structural changes characterized by fibrosis
in L-NAME rats. In rats receiving either captopril or
C. zeylanicum extract, the left ventricular histological
injury was significantly attenuated (Figure 5B).Effects of the methanol extract of C. zeylanicum on tissue
nitric oxide
Aortic and cardiac content in NO are represented in
Figure 6. In rats treated only with L-NAME, both aortic
and cardiac NO concentration decrease significantly
(p < 0.01) by 39.4% and 45.2% respectively as compared
to the control. The methanol extract of C. zeylanicum
significantly prevented the deleterious effects of L-
NAME in the tissue NO content. It increased by 47.7%
and 38.4% the concentration of NO in the aortic and
cardiac tissues respectively compared to the L-NAME
group.Effects of the methanol extract from C. zeylanicum on the
plasma lipid profile
The oral administration of L-NAME (40 mg/kg) to rats
resulted in an elevated plasma lipid profile (Table 1). L-
NAME treated rats showed significantly (p < 0.01)
higher levels of plasma triglycerides, total cholesterol,
LDL-cholesterol and significantly (p < 0.001) lower
levels of HDL-cholesterol compared to the normal





















































Figure 4 Effects of the chronic treatment on the aorta, heart and left ventricle relative weight. Values are Mean±SEM (n=5); γp<0.001
significantly different compared to the control group; **p<0.01 and ***p<0.001 significantly different compared to the L-NAME group.
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Cinnamomum zeylanicum (300 mg/kg/day) significantly
modulated the lipid profile in animals receiving con-
comitantly L-NAME, reducing triglycerides and total
cholesterol by 38.10% and 32.1%, respectively. The
extract increased the level of plasma HDL-cholesterol
by 58.4% while reducing that of LDL-cholesterol by
75.3%, with and atherogenic index closer to that of the
control untreated rats.Discussion
This study investigated the acute and chronic antihy-
pertensive effects of the stem bark methanol extract of
Cinnamomum zeylanicum in L-NAME-induced hyper-
tensive rats and its effects on lipid metabolism in
chronic hypertensive rats. In this model, inhibition
of NO-synthase permits the evaluation of the nitric
oxide pathway, a physiologically important vasodilator,




Figure 5 Representative photographs showing aortic and left ventricular histomorphologies respectively stained with Hematoxylin &
Eosin and Van Gieson trichrome. Magnification: 400X.
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of Cinnamomum zeylanicum methanol extract to L-
NAME-induced hypertensive rats caused a significant
decrease in mean arterial blood pressure (MABP) that
last more than an hour after administration. In animals
treated chronically with L-NAME, arterial hyperten-
sion associated with both cardiovascular hypertrophy
and histological damages were observed. It is well
known that L-NAME, administered either acutely by
intravenous route or chronically by the oral induced
sustained hypertension [16,21,22]. But Chaswal et al.
[23] showed that the acute hypertension provoked by
L-NAME administration may not involve the renin
angiotensin system which is at least partially respon-
sible for the chronic response. The fact that MECZ
could reduce both the acute and chronic hypertensioninduced by L-NAME indicates that it may use another
pathway. Previous studies using the aqueous extract of
C. zeylanicum have demonstrated that this plant pos-
sesses both endothelium-dependent and -independent
vasodilating properties [14]. Therefore, we postulate
that the acute antihypertensive effect of our plant
extract might be mainly due to its ability to reduce the
peripheral resistance via its vasodilating activities even
though its effect on the renin-angiotensin system,
which plays a pivotal role in the development of
chronic L-NAME hypertension, cannot be rule out. It
is also well known that in this model of experimental
arterial hypertension, the sympathetic system tone and
baroreflex to phenylephrine are significantly increased
[23]. MECZ could also interfere with this system.
Permanent increase in systemic blood pressure often























































Figure 6 Effects of the chronic treatment on aorta and cardiac
NO content. Values are Mean±SEM (n=5); βp<0.01 significantly
different compared to the control group; *p<0.05, **p<0.01 and
***p<0.001 significantly different compared to the L-NAME group.
Table 1 Effects of the methanol extract from C. zeylanicum on
Treatment Triglycerides (mg/dl) Total cholesterol (mg/dl) HDL-
Control 53.48 ± 3.36 50.63 ± 2.07
L-NAME 81.10 ± 3.80β 83.13 ± 4.02γ
L-N + Capto 45.74 ± 3.36** 48.12 ± 2.09***
L-N + MECZ 50.16 ± 3.33* 56.46 ± 5.29***
n = 5; βp < 0.01 and γp < 0.001 significantly different compared to the control; *p < 0
NAME group received only L-NAME 40 mg/kg/day. L-N + Capto received L-NAME pl
extract (300 mg/kg/day).
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the present study, it was found that chronic treatment
with L-NAME increases the cardiac and aorta weights.
Additionally, histological analysis showed the thickness
of the vascular wall as well as fibroblast infiltration in
the myocardium. These effects were significantly
reversed by MECZ and captopril. Results with capto-
pril corroborate many other previous works [26,27]
and further confirm the involvement of the renin-
angiotensin system in the development of this model
of arterial hypertension. As there is a tight relationship
between the renin-angiotensin system and the sym-
pathetic system, the inhibition of one may lead to the
inhibition of the other, as it can be clearly see in the
case of captopril. So, no obvious mechanism can be
attributed to MECZ. Another interesting fact is that
MECZ was able to increase NO production in cardio-
vascular organs, namely the aorta and the heart. Thus,
the antihypertensive as well as the antihypertrophic
effects of MECZ may be at least partially attributed to
the increase in NO production, which is known as an
inhibitor to cell proliferation. Moreover, by stimulating
cardiovascular NO synthesis, the plant extract could
induces vasorelaxation, improves arterial wall compli-
ance and control of blood pressure. Hypertension and
hyperlipidemia are two concomitant cardiovascular
risk factors. Therefore, in order to reduce cardiovascu-
lar risk, it is important to regulate hypertension as well
as dyslipidemia, which is known as a qualitative or
quantitative modification of one or several parameters
of the plasma lipids [28]. The results of this study indicated
a dyslipidemia in rats receiving L-NAME. The dyslipidemia
observed was characterized by hypertriglyceridemia, hyper-
cholesterolemia, and high rate of LDL-cholesterol (LDL-C)
coupled with low level of HDL-cholesterol (HDL-C. The
dyslipidemia observed in L-NAME-induced hypertensive
rats, was significantly managed by both the captopril and
MECZ with the concentration of triglycerides, total choles-
terol, LDL-C or HDL-C, closer to that of normal rats.
These results clearly demonstrated both the hypotriglyceri-
demic and hypocholesterolemic properties of the plant
extract, which might contribute to the cardiovascular prop-
tective effects of MECZ. The pharmacological activities of
MECZ might be explained by the presence oflipid profile in L-NAME hypertensive rats
cholesterol (mg/dl) LDL-cholesterol (mg/dl) Atherogenic index
48.76 ± 3.13 5.51 ± 3.68 1.06 ± 0.31
17.57 ± 2.82β 38.52 ± 4.29β 5.35 ± 0.48γ
40.40 ± 3.32** 4.50 ± 3.96*** 1.50 ± 0.70***
42.26 ± 3.83** 9.50 ± 3.08*** 1.41 ± 0.18***
.05, **p < 0.01 and ***p < 0.001 significantly different compared to L-NAME. L-
us captopril (20 mg/kg/day) while L-N +MECZ received L-NAME plus
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the plant. These bioactive phytomolecules are known to
possess vasorelaxant, antihypertensive and antihyperlipi-
demic effects [29-31].
Conclusion
In conclusion, this study demonstrated the acute and
chronic antihypertensive properties of the methanol
extract of Cinnamomum zeylancum stem bark in NO-
deficient hypertensive rats. The acute antihypertensive
effects might be partially due to the reduction of the
peripheral arterial resistance by thwarting the acute
inhibitory effect of L-NAME on eNOS. While, the
long-term antihypertensive effects could be attributed
to the ability of the plant active phytomolecules to
inhibit cardiovascular remodelling, to improve arterial
wall compliance and to prevent endothelial impair-
ment through its antidyslipidemic effects.
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